Criteria for disease activity in Wegener's granulomatosis: a requirement for longitudinal clinical studies

APMIS Suppl. 1990;19:37-9. doi: 10.1111/j.1600-0463.1990.tb05725.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Granulomatosis with Polyangiitis / drug therapy
  • Granulomatosis with Polyangiitis / pathology
  • Granulomatosis with Polyangiitis / physiopathology*
  • Humans
  • Longitudinal Studies

Substances

  • Adrenal Cortex Hormones
  • Cyclophosphamide